Company / Shares Outstanding
Mineralys Therapeutics, Inc. Shares Outstanding History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
48.5M
FY2024
5-year range
5.2M / 48.5M
FY2022-FY2024
Trend
+34.1%
vs FY2023
Sector context
#171 of 212
Health Care
What the data says
Mineralys Therapeutics, Inc.'s shares outstanding of 48539795.00 is lower than 81% of companies in the Health Care sector (FY2024). Increased from 5167296.00 to 48539795.00 over the past 2 years.
Based on SEC 10-K filings.
48539795.00 in FY2024.
Increased from 5167296.00 to 48539795.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 212This company 48.5M Sector average 306.7M
▼
-84.2% below sector average
Key checks
Key Insights
- In FY2024, shares outstanding increased 34.1% year-over-year.
- Ranks #171 out of 212 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 48.5M | +34.1% |
| FY2023 | 36.2M | +600.3% |
| FY2022 | 5.2M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026